Stifel initiated coverage on Surrozen with a new price target
$SRZN
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Stifel initiated coverage of Surrozen with a rating of Buy and set a new price target of $19.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/30/2025 | $32.00 | Buy | H.C. Wainwright |
| 1/3/2025 | $45.00 | Neutral → Buy | Guggenheim |
| 10/11/2021 | $11.00 | Buy | B of A Securities |
| 9/15/2021 | $20.00 | Buy | Guggenheim |
| 9/7/2021 | $19.00 | Buy | Stifel |